What is Aumet?
Aumet operates as a sophisticated B2B digital platform designed to bridge the gap between pharmaceutical manufacturers, distributors, and healthcare providers. By functioning as an AI-driven marketplace, the company addresses critical inefficiencies in medical procurement and inventory management. Its platform facilitates real-time data exchange, which is essential for maintaining medicine availability and enhancing transparency within complex healthcare supply chains. As the industry shifts toward digital-first operations, Aumet provides the scalable infrastructure necessary for healthcare commerce to thrive across diverse regional markets, effectively reducing operational friction for all stakeholders involved.
How much funding has Aumet raised?
Aumet has raised a total of $12M across 1 funding round:
Series A
$12M
Series A (2026): $12M with participation from Emkan Capital, Qatar Development Bank, Shorooq Partners, and Right Side Capital Management
Key Investors in Aumet
Emkan Capital
Emkan Capital is an investment firm focused on mentoring and investing in early-stage technology companies in the MENA region, providing growth capital and access to global co-investors.
Qatar Development Bank
Qatar Development Bank is dedicated to supporting the growth and diversification of businesses in Qatar, offering comprehensive resources to foster a thriving startup ecosystem.
Shorooq Partners
Shorooq Partners is a leading alternative investments manager in the MENA region, specializing in venture capital and private credit to fuel the growth of visionary founders.
What's next for Aumet?
With the successful closure of this major enterprise-level funding, Aumet is set to scale its operations and deepen its market penetration. The strategic focus will likely center on expanding its AI-driven decision support capabilities and broadening its footprint in emerging markets where pharmaceutical supply chain optimization is in high demand. By utilizing this capital, the company aims to solidify its position as a foundational layer in the global healthcare commerce stack, fostering long-term growth and operational excellence for its partners. The involvement of high-caliber investors suggests a strong trajectory toward market leadership and sustained innovation in the health-tech space.
See full Aumet company page
